Alexopoulos Athanasios Internist Oncologist

Doctoral thesis

• Doctoral Thesis: “Cancer Cachexia” University of Athens.

Fellowship in Societies, Membership in Journal Editorial Committees

• Board member in Hellenic society of cancer research 

• Board member of Hellenic society of clinical oncologists 

• Hellenic Breast Cancer society 

• ESMO

• EORTC Breast Cooperative Group

• Board member of Hellenic society of Psychosocial Oncology

• Editorial board of medical edition “Hellenic Oncology”

Editorial Boards:

• Editorial board of medical edition “Hellenic Oncology”

Work Experience

• Liver Unit Kings College Hospital London 

• Guys Hospital Clinical London Oncology and Breast Unit

• Residencies and fellowships: 

• Medical Oncologist in Saint Savvas Hospital for 27 years 

• Medical Oncologist in Hygeia Hospital since 2007

Clinical & Research Interest

Clinical Interest:

• Clinical interest in solid tumors with more interest in Breast Cancer

Research Interest:

• Research interest in all areas of cancer care related to Breast Cancer, endometrial cancer, ovarian cancer, NCSLC, bladder cancer, liver, cholangiocarcinoma and pancreatic cancer.

• My research is focused on prevention of Breast Cancer, prevention of recurrence after surgery, adjuvant treatment and treatment of recurrences. 

Recent Publications

• Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast can-cer in Greece: An evaluation study Annals of Oncology 25 2014 and BMC Health Serv Res. 2015 Aug

• A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines J Cancer Res Cin Oncol. 2010 Jan

• Safety and efficacy of trastuzumab every 3 weeks combined with cytotoxic chemotherapy in patients with HER-2 positive recurrent breast cancer: find-ings from a case series Oncologie. 2005 Nov 

• In vivo synergism between docetaxel and gemcitabine in patients with meta-static breast cancer: general concepts and future perspectives Semin Oncol. 2004 Apr 

• Phase II sudy of pegylated liposomal doxorubicin (Caelyx) and docetaxel as first-line treatment in metastatic breast cancer Ann Oncol. 2004 Jun

• Evidence for in vivo synergism between docetaxel and gemcitabine in pa-tients with metastatic breast cancer Ann Oncol. 2004 Jan

• Gemcitabine plus irinotecan in breast cancer patients pretreated with tax-anes and anthracyclines: a multicenter phase II study Oncology. 2003

• Salvage treatment of metastatic breast cancer with docetaxel and car-boplatin. A multicenter phase II trial Oncology. 2003

• Docetaxel in combination with mitixantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study Ann Oncol. 2001 Jun

• Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomized multicenter trial Lancet. 2001 May